Sutro Biopharma

(NASDAQ) STRO

Current Price$36.82

Market Cap$606.69M

Since IPO (2018)-76%

5 Year-82%

1 Year+249%

1 Month+47%

Sutro Biopharma Financials at a Glance

Market Cap

$606.69M

Revenue (TTM)

$102.48M

Net Income (TTM)

$191.09M

EPS (TTM)

$-22.65

P/E Ratio

-1.62

Dividend

$0.00

Beta (Volatility)

1.28 (Average)

Dividend

$0.00

Beta (Volatility)

1.28 (Average)

Price

$36.82

Volume

Open

$36.56

Price

$36.82

Volume

Open

$36.56

Previous Close

$36.82

Daily Range

$36.22 - $39.00

52-Week Range

$6.74 - $39.10

Dividend

$0.00

Beta (Volatility)

1.28 (Average)

Price

$36.82

Volume

Open

$36.56

Previous Close

$36.82

Daily Range

$36.22 - $39.00

52-Week Range

$6.74 - $39.10

STRO News

scientist-looking-down-into-a-microscope-getty

Why Sutro Biopharma Stock Is Losing Ground Today

Cory RenauerJan 6, 2022

Why Sutro Biopharma Blasted 33% Higher on Friday

Eric VolkmanDec 4, 2020

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sutro Biopharma

Industry

Biotechnology

Sector

Health Care

Employees

137

CEO

Jane Chung

Website

www.sutrobio.com

Headquarters

South San Francisco, CA 94080, US

STRO Financials

Key Financial Metrics (TTM)

Gross Margin

98%

Operating Margin

-2%

Net Income Margin

-2%

Return on Equity

-1810%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

-61.73%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$606.69M

Shares Outstanding

16.57M

Volume

Avg. Volume

200.34K

Financials (TTM)

Gross Profit

$95.16M

Operating Income

$104.95M

EBITDA

$97.63M

Operating Cash Flow

$177.23M

Capital Expenditure

$1.70M

Free Cash Flow

$178.93M

Cash & ST Invst.

$141.43M

Total Debt

$15.67M

Sutro Biopharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$11.65M

-21.4%

Gross Profit

$10.02M

-32.3%

Gross Margin

86.06%

N/A

Market Cap

$606.69M

N/A

Market Cap/Employee

$2.26M

N/A

Employees

269

N/A

Net Income

$46.76M

+35.4%

EBITDA

$32.03M

+46.2%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$93.78M

-131.9%

Accounts Receivable

$3.98M

-53.8%

Inventory

$0.00

N/A

Long Term Debt

$227.43M

+1351.0%

Short Term Debt

$7.78M

+4.1%

Return on Assets

-1.10%

N/A

Return on Invested Capital

-1.56%

N/A

Free Cash Flow

$26.62M

+63.4%

Operating Cash Flow

$26.43M

+63.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

STTKShattuck Labs, Inc.

STTKShattuck Labs, Inc.$7.15+0.85%

ARTVArtiva Biotherapeutics, Inc.

ARTVArtiva Biotherapeutics, Inc.$10.24+17.43%

IFRXInflaRx N.V.

IFRXInflaRx N.V.$2.07+4.55%

CNTBConnect Biopharma Holdings Limited

CNTBConnect Biopharma Holdings Limited$2.47-2.37%

KLRSKalaris Therapeutics Inc

KLRSKalaris Therapeutics Inc$5.52+0.18%

DTILPrecision BioSciences, Inc.

DTILPrecision BioSciences, Inc.$7.15+3.62%

PLRXPliant Therapeutics, Inc.

PLRXPliant Therapeutics, Inc.$1.22+0.83%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$63.54+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.47+0.05%

NOKNokia

NOKNokia$12.91+0.04%

INTCIntel

INTCIntel$94.48-0.00%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$51.65-0.03%

NVDANvidia

NVDANvidia$199.57-0.05%

SOFISoFi Technologies

SOFISoFi Technologies$16.10+0.04%

Questions About STRO

What is the current price of Sutro Biopharma?

Sutro Biopharma is trading at $36.82 per share.

What is the 52-week range for Sutro Biopharma?

Over the past 52 weeks, Sutro Biopharma has traded between $6.74 and $39.10.

How much debt does Sutro Biopharma have?

As of the most recent reporting period, Sutro Biopharma reported total debt of $235.21M.

How much cash does Sutro Biopharma have on hand?

Sutro Biopharma reported $58.13M in cash and cash equivalents in its most recent financial results.

What is Sutro Biopharma’s dividend yield?

Sutro Biopharma does not currently have a dividend yield.

Sutro Biopharma

Sutro Biopharma Financials at a Glance

STRO News

Why Sutro Biopharma Stock Is Losing Ground Today

Why Sutro Biopharma Blasted 33% Higher on Friday

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Sutro Biopharma

STRO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Sutro Biopharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About STRO

What is the current price of Sutro Biopharma?

What is the 52-week range for Sutro Biopharma?

How much debt does Sutro Biopharma have?

How much cash does Sutro Biopharma have on hand?

What is Sutro Biopharma’s dividend yield?

Premium Investing Services